Federal Register Proposed rule and direct final rule: FDA is correcting a typographical error in the codified section of a proposed rule that appeared in the 8/16 Federal Register proposing to amend the biologics regulations by removing, revising, or updating specific regulations applicable to blood, blood components, and source plasma to be more consistent with current practices in the blood industry and to remove unnecessary or outdated requirements. To view this proposed rule, click here.